EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 4th, 2010 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of October 30, 2009, 2009 (the “Effective Date”), by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and Andrew K. W. Powell (the “Executive”).
CORNERSTONE THERAPEUTICS INC. Restricted Stock AgreementRestricted Stock Agreement • March 4th, 2010 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • Delaware
Cornerstone Therapeutics Inc. (the “Company”) has selected you to receive the restricted stock award described above, which is subject to the provisions of the Company’s 2004 Stock Incentive Plan (the “Plan”), and the terms and conditions contained in this Restricted Stock Agreement (the “Agreement”). Please confirm your acceptance of this restricted stock award and of the terms and conditions of this Agreement by signing a copy of this Agreement where indicated below.
AMENDMENT NO. 1 TO SUPPLY AND MARKETING AGREEMENTSupply and Marketing Agreement • March 4th, 2010 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
This Amendment No. 1 to Supply and Marketing Agreement (this “Amendment”) is entered into on the 18th day of December, 2009 by and between Aristos Pharmaceuticals, Inc., a Delaware corporation with its principal offices located at 1255 Crescent Green Drive, Suite 250, Cary, NC 27518 (“ARISTOS”), and Sovereign Pharmaceuticals, Ltd., a Texas limited partnership with its principal offices located at 7590 Sand Street, Fort Worth, TX, 76118 (“SOVEREIGN”), and shall be effective as of the 30th day of September, 2009.
October 16, 2009Separation Agreement • March 4th, 2010 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
This Separation Letter Agreement and General Release (the “Agreement”) sets forth and confirms the terms of the separation package that you are eligible to receive pursuant to your Amended and Restated Executive Employment Agreement dated May 6, 2009 (the “Employment Agreement”) by and between Cornerstone Therapeutics Inc. (the “Company”) and you (“you” or the “Employee”) as a result of the Company’s termination of your employment with the Company without “cause.” To receive the severance benefits, you must enter into a binding severance agreement drafted by and satisfactory to the Company. You will have twenty-one (21) days from your receipt of this Agreement to consider it and once you have signed this Agreement, you will have seven (7) days to revoke your acceptance as set forth in Paragraphs Nos. 8 and 19 below. Please note that the earliest you can accept this Agreement is the Termination Date (as defined below). Please read this Agreement carefully and review it with your attorne
